Literature DB >> 30371609

Computerized Image Analysis to Differentiate Benign and Malignant Breast Tumors on Magnetic Resonance Diffusion Weighted Image: A Preliminary Study.

Ning Mao, Qinglin Wang, Meijie Liu, Jianjun Dong1, Chuanguang Xiao2, Ning Sun2, Xuexi Zhang3, Haizhu Xie, Ping Yin, Nan Hong.   

Abstract

PURPOSE: This work aims to determine the feasibility of using a computer-aided diagnosis system to differentiate benign and malignant breast tumors on magnetic resonance diffusion-weighted image (DWI).
MATERIALS AND METHODS: Institutional review board approval was obtained. This retrospective study included 76 patients who underwent breast magnetic resonance imaging before neoadjuvant chemotherapy from March 10, 2017, to October 12, 2017, with a total of 80 breast tumors including 40 cases of breast cancers and 40 cases of benign breast tumors. The textural features of DWI images were analyzed. The area under the receiver operating characteristic curve was calculated to evaluate the diagnostic efficiency of texture parameters. Multiple linear regression analysis was used to determine the efficiency of texture parameters for distinguishing the 2 types of breast tumors.
RESULTS: Computer vision algorithms were applied to extract 67 imaging features from lesions indicated by a breast radiologist on DWI images. A total of 19 texture feature parameters, such as variance, standard deviation, intensity, and entropy, out of 67 texture parameters were statistically significant in the 2 sets of data (P < 0.05). By comparing the receiver operating characteristic curves, we found that the mean and relative deviations exhibited high diagnostic values in differentiating between benign and malignant tumors. The accuracy of Fisher discriminant analysis for the 2 types of breast tumors was 92.5%.
CONCLUSIONS: Breast lesions exhibit certain characteristic features in DWI images that can be captured and quantified with computer-aided diagnosis, which enables good discrimination of benign and malignant breast tumors.

Entities:  

Mesh:

Year:  2019        PMID: 30371609     DOI: 10.1097/RCT.0000000000000793

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  6 in total

1.  Preliminary study on discriminating HER2 2+ amplification status of breast cancers based on texture features semi-automatically derived from pre-, post-contrast, and subtraction images of DCE-MRI.

Authors:  Lirong Song; Hecheng Lu; Jiandong Yin
Journal:  PLoS One       Date:  2020-06-17       Impact factor: 3.240

2.  Radiomics Nomogram of DCE-MRI for the Prediction of Axillary Lymph Node Metastasis in Breast Cancer.

Authors:  Ning Mao; Yi Dai; Fan Lin; Heng Ma; Shaofeng Duan; Haizhu Xie; Wenlei Zhao; Nan Hong
Journal:  Front Oncol       Date:  2020-10-27       Impact factor: 6.244

3.  Contrast-Enhanced Spectral Mammography-Based Radiomics Nomogram for the Prediction of Neoadjuvant Chemotherapy-Insensitive Breast Cancers.

Authors:  Zhongyi Wang; Fan Lin; Heng Ma; Yinghong Shi; Jianjun Dong; Ping Yang; Kun Zhang; Na Guo; Ran Zhang; Jingjing Cui; Shaofeng Duan; Ning Mao; Haizhu Xie
Journal:  Front Oncol       Date:  2021-02-22       Impact factor: 6.244

4.  Pharmacokinetic parameters and radiomics model based on dynamic contrast enhanced MRI for the preoperative prediction of sentinel lymph node metastasis in breast cancer.

Authors:  Meijie Liu; Ning Mao; Heng Ma; Jianjun Dong; Kun Zhang; Kaili Che; Shaofeng Duan; Xuexi Zhang; Yinghong Shi; Haizhu Xie
Journal:  Cancer Imaging       Date:  2020-09-15       Impact factor: 3.909

5.  Contrast-Enhanced Spectral Mammography-Based Radiomics Nomogram for Identifying Benign and Malignant Breast Lesions of Sub-1 cm.

Authors:  Fan Lin; Zhongyi Wang; Kun Zhang; Ping Yang; Heng Ma; Yinghong Shi; Meijie Liu; Qinglin Wang; Jingjing Cui; Ning Mao; Haizhu Xie
Journal:  Front Oncol       Date:  2020-10-30       Impact factor: 6.244

6.  Texture Analysis of DCE-MRI Intratumoral Subregions to Identify Benign and Malignant Breast Tumors.

Authors:  Bin Zhang; Lirong Song; Jiandong Yin
Journal:  Front Oncol       Date:  2021-07-08       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.